Efficacy and Safety of Etoricoxib+Diacerein in Osteoarthritis.

NCT07549386 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

123

Enrollment

INDUSTRY

Sponsor class

Conditions

Pain Management
Osteoarthritis

Interventions

DRUG: Etoricoxib 90 mg + diacerein 50 mg
DRUG: Meloxicam 15 mg + diacerein 50 mg

Sponsor

Laboratorios Liomont

Collaborators

[object Object]